Rowena Dolor added to PCORI Advisory Panel on Clinical Trials

September 16, 2020

 

Rowena Dolor
Rowena Dolor, MD, MHS

Rowena Dolor, MD, MHS, has been appointed by the Patient-Centered Outcomes Research Institute (PCORI) as a member of its Advisory Panel on Clinical Trials.

Dolor will join other members of the panel in applying her experience and expertise to helping PCORI refine and prioritize the research it funds. She will also ensure that the research PCORI supports centers on the outcomes that matter to patients and other healthcare decision makers. PCORI is an independent, nonprofit organization authorized by Congress to fund research that will provide patients, their caregivers and clinicians with the evidence-based information needed to make better-informed healthcare decisions.

Dolor was selected on the basis of her experience, expertise and ability to contribute to the panel’s mission. Panel members represent a broad range of healthcare stakeholder groups and perspectives, including patients, family caregivers, clinicians, drug and device makers and researchers, among others.

Dolor has directed the Primary Care Research Consortium (PCRC) since 1996, and in that time she and her team have tackled more than 100 studies with the Duke University Health System and other community-based clinicians. She also serves as a co-investigator for the MURDOCK Study and an Associate Professor with Tenure in the Department of Medicine.

More information about the Advisory Panel on Clinical Trials, including its scope of work and a list of all members, is available on the PCORI website.